U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 1 to 20 of 122

Tests names and labsConditionsGenes, analytes, and microbesMethods

Hemochromatosis

Genetics Laboratory Shodair Children's Hospital
United States
11
  • T Targeted variant analysis

HFE Targeted Mutation Analysis

GENETIX Centro de Investigación en Genética Humana y Reproductiva
Colombia
11
  • T Targeted variant analysis

Diagnostic génotypique direct au locus HFE (hémochromatose héréditaire)

Laboratoire de Diagnostic Moleculaire Hopital Saint-Francois d'Assise du CHU de Québec UL
Canada
11
  • T Targeted variant analysis

HFE-Associated Hereditary Hemochromatosis

Molecular Genetics Laboratory London Health Sciences Centre
Canada
11
  • T Targeted variant analysis

HFE-Associated Hereditary Hemochromatosis

Clinical Molecular Genetics Laboratory Johns Hopkins All Children's Hospital
United States
11
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

HFE hereditary hemochromatosis

Immuno-Molecular Pathology University of Kentucky
United States
11
  • T Targeted variant analysis

HFE Targeted Mutation Analysis for Hemochromatosis

Molecular Diagnostics Laboratory Duke University Health System
United States
11
  • T Targeted variant analysis

Haemochromatosis

Molecular Genetics Laboratory London Health Sciences Centre
Canada
11
  • T Targeted variant analysis

HFE - NGS including CNV analysis

Centogene US, LLC - The Rare Disease Company
United States
61
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

BMP2 - NGS including CNV analysis

Centogene US, LLC - The Rare Disease Company
United States
31
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

HFE - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
61
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

BMP2 - NGS including CNV analysis

Centogene AG - the Rare Disease Company
Germany
31
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Iron Related Disorders Panel

Invitae
United States
3927
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Skeletal Disorders Panel

Invitae
United States
624349
  • D Deletion/duplication analysis

Invitae Limb and Digital Malformations Panel

Invitae
United States
367178
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hemochromatosis, 235200, Autosomal recessive (Symptomatic form of hemochromatosis type 1) (MLPA)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • D Deletion/duplication analysis

Hemochromatosis, 235200, Autosomal recessive (Symptomatic form of hemochromatosis type 1) (HFE gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • C Sequence analysis of the entire coding region

HFE hemochromatosis, modifier of, 235200, Autosomal recessive (Symptomatic form of hemochromatosis type 1) (BMP2 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Genetic Diagnosis and Research Centre
Turkey
11
  • C Sequence analysis of the entire coding region

Health

Aventus Biolabs
United States
6130
  • T Targeted variant analysis

Invitae Comprehensive Carrier Screen without X-linked Disorders

Invitae
United States
228279
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 122

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.